Molar pregnancy

New England Journal of Medicine

Volumn 360, Issue 16, 2009, Pages 1639-1645

  Berkowitz, Ross S ^a   Goldstein, Donald P ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ARTICLE; CHORIOCARCINOMA; CLINICAL FEATURE; FETUS ELECTROCARDIOGRAPHY; FETUS HEART RATE; GESTATIONAL AGE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYDATIDIFORM MOLE; METASTASIS; MISSED ABORTION; PATIENT MONITORING; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; RADIODIAGNOSIS; VAGINA BLEEDING; FEMALE; FETUS ECHOGRAPHY; GENETICS; PATHOLOGY; PRACTICE GUIDELINE; REVIEW;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYDATIDIFORM MOLE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 64749095793     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp0900696     Document Type: Article

References (56)

1. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996;335:1740-1748
2. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-27
3. Szulman AE, Surti U. Idem. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-671
4. Montes M, Roberts D, Berkowitz RS, Genest DR. Prevalence and significance of implantation site trophoblast atypia in hydatidiform moles and in spontaneous abortions. Am J Clin Pathol 1996;105:411-416 (Pubitemid 26105134)
5. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977;268:633-634 (Pubitemid 8227851)
6. Yamashita K, Wake N, Araki T, Ichinoe R, Makoto K. Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol 1979;135:597-600. (Pubitemid 10232347)
7. Azuma C, Saji F, Tokugawa Y, et al. Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol 1991;40:29-33.
8. The diagnosis and management of molar pregnancy. In: Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasms: clinical principles of diagnosis and management. Philadelphia: Saunders, 1982:143-175
9. Berkowitz RS, Goldstein DP. Presentation and management of molar pregnancy. In: Hancock BW, Newlands ES, Berkowitz RS, eds. Gestational trophoblastic disease. London: Chapman & Hall, 1997:127-142
10. Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT. Hydatidiform mole: diagnosis, management and long-term follow-up of 347 patients. Obstet Gynecol 1975;45:1-8.
11. Kohorn EI. Molar pregnancy: presentation and diagnosis. Clin Obstet Gynecol 1984;27:181-191 (Pubitemid 14152860)
12. Soto-Wright V, Bernstein MR, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-779
13. Felemban AA, Bakri YN, Alkharif HA, Altuwaijri SM, Shalhoub J, Berkowitz RS. Complete molar pregnancy: clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med 1998;43:11-13 (Pubitemid 28076679)
14. Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol 1985;66:677-681 (Pubitemid 16216159)
15. Czernobilsky B, Barash A, Lancet M. Partial moles: a clinicopathologic study of 25 cases. Obstet Gynecol 1982;59:75-77 (Pubitemid 12222123)
16. Szulman AE, Surti U. The clinicopathological profile of the partial hydatidiform mole. Obstet Gynecol 1982;59:597-602.
17. Feltmate CM, Growdon WB, Wolfberg AJ, et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 2006;51:902-906
18. Mosher R, Goldstein DP, Berkowitz RS, Bernstein MR, Genest DR. Complete hydatidiform mole: comparison of clinicopathologic features, current and past. J Reprod Med 1998;43:21-27 (Pubitemid 28076681)
19. Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000;16:188-191 (Pubitemid 33111781)
20. Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJW, Hobbins JC. New criteria for the diagnosis of gestational trophoblastic disease. Obstet Gynecol 1985;66:553-558 (Pubitemid 16236445)
21. Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol 1989;73:414-418 (Pubitemid 19063623)
22. Naumoff P, Szulman AE, Weinstein B, Mazer J, Surti U. Ultrasonography of partial hydatidiform mole. Radiology 1981;140:467-470 (Pubitemid 11039979)
23. Menczer J, Modan M, Serr DM. Prospective follow-up of patients with hydatidiform mole. Obstet Gynecol 1980;55:346-349 (Pubitemid 10129709)
24. Genest DR, Laborde O, Berkowitz RS, Goldstein DP, Bernstein MR, Lage J. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol 1991;78:402-409
25. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol 2003;6:69-77. (Pubitemid 36323629)
26. Fukunaga M. Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol 2002;33:1188-1192 (Pubitemid 36020068)
27. Genest DR, Dorfman DM, Castrillon DH. Ploidy and imprinting in hydatidiform moles: complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med 2002;47:342-346 (Pubitemid 34553232)
28. Thaker HM, Berlin A, Tycko B, et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med 2004;49:630-636
29. Hancock BW, Tidy JA. Current management of molar pregnancy. J Reprod Med 2002;47:347-354 (Pubitemid 34553233)
30. Berkowitz RS, Goldstein DP, Bernstein MR. Evolving concepts of molar pregnancy. J Reprod Med 1991;36:40-44
31. Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: a progress report. J Reprod Med 2002;47:445-450 (Pubitemid 34680206)
32. Idem. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 1982;59:78-84.
33. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591-595 (Pubitemid 13149418)
34. Morrow CP, Kletzky OA, DiSaia PJ, Townsend DE, Mishell DR, Nakamura RM. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 1977;128:424-430 (Pubitemid 8136182)
35. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathologic and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996;28:101-110 (Pubitemid 26052005)
36. Morrow CP. Postmolar trophoblastic disease: diagnosis, management, and prognosis. Clin Obstet Gynecol 1984;27:211-220 (Pubitemid 14152863)
37. Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole: incidence and outcome. J Reprod Med 2006;51:764-766 (Pubitemid 44606962)
38. Feltmate CM, Bartorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003;101:732-736 (Pubitemid 36390063)
39. Kerkmeijer LGW, Wielsma S, Massuger LFAG, Sweep FCGJ, Thomas CMG. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Gynecol Oncol 2007;106:142-146 (Pubitemid 46908741)
40. Kerkmeijer L, Wielsma S, Bekkers R, Pyman J, Tan J, Quinn M. Guidelines following hydatidiform mole: a reappraisal. Aust N Z J Obstet Gynaecol 2006;46:112-118
41. Pisal N, Tidy J, Hancock B. Gestational trophoblastic disease: is intensive follow up essential in all women? BJOG 2004;111:1449-1451
42. Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M. Persistent trophoblastic disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol 2006;46:119-123
43. Batorfi J, Vegh G, Szepesi J, Szigetvari I, Doszpod J, Fulop V. How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data. Eur J Obstet Gynecol Reprod Biol 2004;112:95-97 (Pubitemid 37543737)
44. Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551-554 (Pubitemid 40458844)
45. Wolfberg AJ, Growdon WB, Feltmate CM, et al. Low risk of relapse after achieving undetectable hCG levels in women with partial molar pregnancy. Obstet Gynecol 2006;108:393-396
46. Lavie I, Rao GG, Castrillon DH, Miller DS, Schorge JO. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. Am J Obstet Gynecol 2005;192:1362-1364
47. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-1983. Lancet 1986;2:673-677
48. Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol 1979;86:782-792 (Pubitemid 10224175)
49. Curry SL, Schlareth JB, Kohorn EI, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1989;160:805-811
50. Berkowitz RS, Goldstein DP, Marean AR, Bernstein M. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol 1981;58:474-477 (Pubitemid 12232156)
51. Costa HLFF, Doyle P. Influence of oral contraceptives in the development of postmolar trophoblastic neoplasia - a systematic review. Gynecol Oncol 2006;100:579-585 (Pubitemid 43250627)
52. Wenzel L, Berkowitz R, Robinson S, Bernstein MR, Goldstein D. The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol 1992;46:74-81.
53. Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med 2008;53:481-486
54. Kim DS, Moon H, Kim KT, Moon YJ, Hwang YY. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 1986;67:690-694 (Pubitemid 16111929)
55. Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med 2001;46:110-116 (Pubitemid 32205253)
56. Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol 2004;93:575-585